HQL Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 May 2024 @ 16:00):

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe...

Stats
Today's Volume	58 440.00
Average Volume	83 063.00
Market Cap	364.31M
Next earnings date	( $0 ) 2024-06-25
Last Dividend	$0.480 ( 2024-05-22 )
Next Dividend	$0 ( N/A )
P/E	16.86
ATR14	$0.0100 (0.08%)

Insider Trading

Date	Person	Action	Amount	type
2024-05-30	Saba Capital Management, L.p.	Buy	669	Common Stock
2024-05-29	Saba Capital Management, L.p.	Buy	38 033	Common Stock
2024-05-28	Saba Capital Management, L.p.	Buy	8 714	Common Stock
2024-05-23	Saba Capital Management, L.p.	Buy	1 303	Common Stock
2024-05-15	Saba Capital Management, L.p.	Buy	34 755	Common Stock

INSIDER POWER
100.00
Last 68 transactions
Buy: 808 218 \| Sell: 55 759

Volume Correlation

Long: 0.09 (neutral)

Short: 0.35 (neutral)

Signal:(69.5) Neutral

Tekla Life Sciences Correlation

10 Most Positive Correlations

10 Most Negative Correlations
INFA	-0.812

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Tekla Life Sciences Correlation - Currency/Commodity

0.10
( neutral )

-0.08
( neutral )

0.00
( neutral )

0.25
( neutral )

-0.03
( neutral )

Tekla Life Sciences Financials

Annual	2023
Revenue:	$23.52M
Gross Profit:	$18.28M (77.71 %)
EPS:	$0.830

FY	2023
Revenue:	$23.52M
Gross Profit:	$18.28M (77.71 %)
EPS:	$0.830

FY	2022
Revenue:	$-103.25M
Gross Profit:	$-108.80M (105.37 %)
EPS:	$-4.07

FY	2021
Revenue:	$65.69M
Gross Profit:	$0.00 (0.00 %)
EPS:	$2.78

Financial Reports:

No articles found.

Tekla Life Sciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
$0.310 (N/A)	$0.310 (N/A)	$0.330 (N/A)	$0.320 (N/A)	$0.320 (N/A)	$0.300 (N/A)	$0.390 (N/A)	$0.480 (N/A)	$0 (N/A)	$0 (N/A)

Tekla Life Sciences Dividend Information - Dividend King

Dividend Sustainability Score: 1.186 - low (50.00%) | Divividend Growth Potential Score: 0.953 - No dividend expected

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	$1.640	1996-11-14
Last Dividend	$0.480	2024-05-22
Next Dividend	$0	N/A
Payout Date	2024-06-28
Next Payout Date	N/A
# dividends	101	--
Total Paid Out	$44.04	--
Avg. Dividend % Per Year	7.65%	--
Score	5.88	--
Div. Sustainability Score	1.186
Div.Growth Potential Score	0.953
Div. Directional Score	1.070	--

Next Divdend (Est)
(2024-07-18)

$0.513 Estimate 72.80 %

Dividend Stability

0.97 Excellent

Dividend Score

5.88

Pay Frequency

Quarterly

Yearly Payout

Year	Amount	Yield
1996	$1.640	10.80%
1997	$0.740	5.38%
1998	$0.360	2.76%
1999	$1.110	9.06%
2000	$4.16	20.50%
2001	$3.14	14.90%
2002	$2.18	10.20%
2003	$1.240	10.10%
2004	$1.365	8.62%
2005	$2.06	13.00%
2006	$1.240	7.90%
2007	$1.170	8.74%
2008	$1.100	8.33%
2009	$0.420	4.59%
2010	$0.520	5.46%
2011	$1.010	9.29%
2012	$1.160	10.00%
2013	$1.390	9.19%
2014	$1.770	8.72%
2015	$2.80	11.20%
2016	$2.07	8.99%
2017	$1.620	9.38%
2018	$1.620	8.18%
2019	$1.400	9.03%
2020	$1.560	8.98%
2021	$1.690	8.71%
2022	$1.360	7.05%
2023	$1.270	8.87%
2024	$0.870	6.34%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NYSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend	Score
LOMA	Dividend King	2023-06-30	Quarterly	2	5.23%	8.53
PVL	Dividend Royal	2023-11-15	Monthly	14	9.37%	8.50
ARR	Dividend Royal	2024-05-14	Monthly	15	11.08%	8.50
ACV	Dividend Royal	2024-06-13	Monthly	10	10.19%	8.50
ACP	Dividend Royal	2024-05-22	Monthly	14	11.88%	8.50
AVK	Dividend Royal	2024-05-14	Monthly	22	9.54%	8.31
AFG	Dividend Royal	2024-04-12	Bi-Monthly	39	9.39%	8.06
JPT	Dividend King	2023-11-02	Monthly	8	4.19%	8.05
VCIF	Dividend Royal	2023-08-18	Monthly	6	8.05%	8.02
EDI	Dividend Royal	2023-12-07	Monthly	13	8.85%	7.94

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.568	1.500	10.00	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0556	1.200	8.15	9.78	[0 - 0.3]
returnOnEquityTTM	0.0538	1.500	-0.513	-0.770	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	0	1.000	-1.111	-1.111	[3 - 30]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.867	1.000	10.00	10.00	[0.2 - 0.8]
operatingProfitMarginTTM	0.568	1.000	0.649	0.649	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0.0978	0.800	-2.68	-2.14	[0.5 - 2]
Total Score				1.186

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	15.95	1.000	8.49	0	[1 - 100]
returnOnEquityTTM	0.0538	2.50	-0.330	-0.770	[0.1 - 1.5]
freeCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
dividendYielPercentageTTM	11.19	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	0.0000000	2.00	0.0000000	0.0000000	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0631	1.500	-3.75	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0000000	1.000	-2.50	0	[0.1 - 0.5]
Total Score				0.953

Tekla Life Sciences Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Tekla Life Sciences

Tekla Life Sciences Investors is a closed-ended equity mutual fund launched and managed by Tekla Capital Management LLC. The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries. The fund primarily invests in growth stocks of small cap companies. It employs fundamental analysis with a focus on factors such as market position for services or products, experience of business management, technological expertise, and the ability either to generate funds internally to finance growth or to secure outside sources of capital to create its portfolio. The fund benchmarks the performance of its portfolio against the NASDAQ Biotech Index and the S&P 500 Index. It was formerly known as H&Q Life Sciences Investors fund. Tekla Life Sciences Investors was formed on February 20, 1992 and is domiciled in the United States.

Realtime updates for Tekla Life Sciences [HQL]

Upcoming Earnings Alert